Materia Ventures

Materia Ventures was a private medical cannabis and wellness company focused on the European market, with operations spanning manufacturing, processing, formulation, and distribution of cannabis and CBD products. The company built an EU-GMP-certified production facility in Malta and a distribution footprint that included Germany, positioning itself as an enabler of regulated medical cannabis access across Europe. Materia emphasized pharma-grade production, regulatory compliance, and downstream supply chain capabilities rather than traditional drug discovery. Its business model centered on producing and supplying medical cannabis products for pharmacy and export channels. In 2023, Jamaican Medical Cannabis Corp. acquired Materia's Malta facility and other assets, and the Malta unit was renamed JMCC Life Sciences, Europe.